Abstract
Tumor necrosis factor-α (TNF-α)plays a central role in the host's immunomodulatoryresponse to infective agents. To evaluate theTNF-α system in patients with chronic hepatitis Cvirus (HCV) infection, plasma, serum, and peripheral bloodmononuclear cells (PBMC) were prospectively collectedfrom 53 patients and 33 healthy control subjects.Circulating TNF-α and TNF receptors were assayed by their respective enzyme immunoassays. Inaddition, TNF-α mRNA was quantitated in PBMC usinga branched DNA assay, and production of TNF-α byPBMC with and without lipopolysaccharide was also assessed. Patients with chronic HCV infectionhad a higher level of circulating TNF-α comparedto healthy control subjects (9.62 ± 6.01 vs 3.66± 1.23 pg/ml, P < 0.001). They also had highercirculating levels of TNF receptors compared to control(CD120a: 3323 ± 1267, pg/ml, N = 49 vs 1855± 422 pg/ml, N = 33, P < 0.001; CD120b: 1290± 650 pg/ml, N = 51, vs 863 ± 207 pg/ml,N = 33, P < 0.001). Plasma TNF-α level correlated with circulatingCD120a (r = 0.52, N = 49, P < 0.001) and weakly withCD120b (r = 0.32, N = 51, P = 0.02). Plasma TNF-αalso correlated with markers of hepatocellular injury, including ALT (r = 0.34, N = 53, P = 0.01) andα-GST (r = 0.31, N = 43, P = 0.042), but not withserum HCV RNA levels. There was no difference in theTNF-α mRNA levels in PBMC between patients with chronic HCV infection (1.4 ± 1.9units/106 cells, N = 8) and healthy control subjects(2.1 ± 1.4 units/106 cells, N = 8, P = NS). Therewas also no difference in the spontaneous production ofTNF-α by PBMC (1 × 106 cells/ml)between patients with chronic HCV infection (14.2± 36.5 pg/ml, N = 11) and healthy subjects (11.9± 14.0 pg/ml, N = 14, P = NS). However, patientswith chronic HCV infection produced more TNF-α upon stimulation withlipopolysaccharide compared to healthy control subjects(1278 ± 693 pg/ml, N = 11, vs 629 ± 689pg/ml, N = 14, P < 0.05). These data indicate thatthe TNF-α system is activated in patients with chronicHCV infection.
Similar content being viewed by others
REFERENCES
Camussi G, Albano E, Tetta C, Bussolino F: The molecular action of tumor necrosis factor alpha. Eur J Biochem 202:3–14, 1991
Dinarello CA, Mier JW: Current concepts, lymphokines. N Engl J Med 317:940–945, 1987
Aria K, Lee F, Miyajima A, Argi N, Yokota T: Cytokines: Coordinators of immune and inflammatory responses. Annu Rev Biochem 59:783–836, 1990
Kull FC: The TNF receptor in TNF-mediated cytotoxicity. Nat Cell Growth Regul 7:254–265, 1988
Scheurich P, Thoma B, Ucer U, Pfizenmaier K: Immunoregulatory activity of recombinant TNF-alpha: Induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol 138:1786–1790, 1987
Lau JYN: Hepatitis C virus: From epidemiology and molecular virology to immunobiology. Hepatology 20:760–762, 1994
Onji M, Kikuchi T, Kumon I, Masumoto T, Nadano S, Kajino K, Ohta Y: Intrahepatic lymphocyte subpopulations and HLA class I antigen expression by hepatocytes in chronic hepatitis C. Hepato-Gastroenterol 108:231, 1992
Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JYN: The role of intrahepatic HCV-specific cytotoxic T cell lymphocytes in chronic hepatitis C. J Immunol 158:1473–1481, 1997
Nelson DR, Lim HL, Oliver D, Qian KP, Davis GL, Lau JYN: α-Glutathione S-transferase: Analysis of its utility in chronic hepatitis C virus infection. Am J Clin Pathol 104:193–198, 1995
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan, et al: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431, 1981
Lau JYN, Davis GL, Brunson ME, Qian KP, Lin HJ, Quan S, DiNello R, Polito AJ, Scornik JC: Hepatitis C virus infection in renal transplant recipients. Hepatology 18:1027–1031, 1993
Lau JYN, Simmonds P, Urdea MS: Implications of variations of conserved regions of hepatitis C virus genome. Lancet 346:425, 1995
Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, et al: Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 74:1093–102, 1993
Simmonds P, Alberti A, Bonino F, Bradley DW, Brechot C, Chan SW, et al: A proposed nomenclature system of genotypes for hepatitis C virus. Hepatology 19:1321–1324, 1994
Kapadia S, Guillermo TA, Mann D: Pitfalls in measuring cytokines. Ann Intern Med 121:149–150, 1994
Urdea MS, Horn T, Fultz TJ, Anderson M, Running JA, Hamren S, et al: Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. Nucleic Acid Symp Ser 23:197–200, 1993
Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judamaier G, Huber C: Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264–274, 1992
Larrea E, Garcia N, Qian C, Civeira M, Prieto J: TNF-α gene expression and the response to Interferon in chronic hepatitis C. Hepatology 2:210–217, 1996
Becker S, Quay J, Soukup J: Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 147:4307–4312, 1991
Gosselin J, Flamand L, D'Addario M, Hiscott J, Menezes J: Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha. J Clin Invest 89:1849–1856, 1992
Henke A, Mohr C, Sprenger H, Graibner C, Stelzner A, Nain M, Gemsa D: Coxsackie virus B3-induced production of timor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes. J Immunol 148:2270–2277, 1992
Sheron N, Lau J, Daniels H, Goka J, Eddleston A, Alexander GM, Williams R: Increased production of tumor necrosis factor alpha in chronic hepatitis B virus infection. J Hepatol 12:241–245, 1991
Kishihara Y, Hayashi J, Yoshimura E, Yamaji K, Nakashima K, Kashiwagi S: IL-1 and TNF-α produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C. Dig Dis Sci 41:315–321, 1996
Gonzalez-Amaro R, Garcia-Monzon C, Garcia-Buey L, Moreno-Otero R, Alonso JL, Yague E, Pivel JP, Fernandez-Ruiz E, Lopez-Cabrera M, Sanchez-Madrid F: Induction of tumor necrosis factor-alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med 179:841–848, 1994
Shinagawa T, Yoshioka K, Kakumu A, Wakita T, Ishikawa T, Itoh Y, Takayanagi M: Apoptosis in cultured rat hepatocytes: The effects of tumor necrosis factor alpha and interferon gamma. J Pathol 165:247–253, 1991
Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker B: Hepatitis C virus-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 67:7522–7532, 1993
Kozeil MJ, Dudley D, Afdel A, Grakoui A, Rice CM, Choo QL, Houghton M, Walker BD: HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C Virus. J Clin Invest 96:2311–2321, 1995
Volpes R, van-den-Oord JJ, De-Vos R, Desmet VJ: Hepatic expression of type A and type B receptors for tumor necrosis factor. J Hepatol 14:361–369, 1992
Rights and permissions
About this article
Cite this article
Nelson, D.R., Lim, H.L., Marousis, C.G. et al. Activation of Tumor Necrosis Factor-α System in Chronic Hepatitis C Virus Infection. Dig Dis Sci 42, 2487–2494 (1997). https://doi.org/10.1023/A:1018804426724
Issue Date:
DOI: https://doi.org/10.1023/A:1018804426724